Correction: Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry

被引：0
|
作者：
Wern Yew Ding
Ameenathul Mazaya Fawzy
Giulio Francesco Romiti
Marco Proietti
Daniele Pastori
Menno V. Huisman
Gregory Y. H. Lip
Ameenathul Mazaya Fawzy
机构：
[1] University of Liverpool,Liverpool Centre for Cardiovascular Science
[2] Liverpool John Moores University and Liverpool Heart & Chest Hospital,Department of Translational and Precision Medicine
[3] Sapienza - University of Rome,Division of Subacute Care
[4] IRCCS Istituti Clinici Scientifici Maugeri,Department of Clinical Sciences and Community Health
[5] University of Milan,Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences
[6] Sapienza University of Rome,Department of Thrombosis and Hemostasis
[7] Leiden University Medical Center,Department of Clinical Medicine, Aalborg Thrombosis Research Unit
[8] Aalborg University,undefined
来源：
Journal of Thrombosis and Thrombolysis | 2024年 / 57卷 / 1期
关键词：
D O I：
10.1007/s11239-023-02904-9
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：178 / 178
相关论文
共 50 条
  • [31] Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry
    Huisman, Menno, V
    Teutsch, Christine
    Lu, Shihai
    Diener, Hans-Christoph
    Dubner, Sergio J.
    Halperin, Jonathan L.
    Ma, Chang-Sheng
    Rothman, Kenneth J.
    Lohmann, Ragna
    Gurusamy, Venkatesh Kumar
    Bartels, Dorothee B.
    Lip, Gregory Y. H.
    CLINICAL RESEARCH IN CARDIOLOGY, 2022, 111 (05) : 548 - 559
  • [32] 2MACE score predicts cardiovascular adverse events in real-world atrial fibrillation patients under rivaroxaban therapy. Data from EMIR study
    Esteve Pastor, M.
    Marin, F.
    Anguita, M.
    Sanmartin, M.
    Rafols, C.
    Arribas Ynsaurriaga, F.
    Baron Esquivas, G.
    Barrios, V.
    Cosin Sales, J.
    Freixa Pamias, R.
    Perez Cabeza, A.
    Vazquez Rodriguez, J. M.
    Lekuona Goya, I.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2484 - 2484
  • [33] Long term cardiovascular risk prediction in Real- World atrial fibrillation patients: Validation of the 2MACE score in the FANTASIIA registry
    Esteve Pastor, M. A.
    Rivera-Caravaca, J. M.
    Roldan, V.
    Roldan-Rabadan, I.
    Muniz, J.
    Cequier, A.
    Bertomeu-Martinez, V.
    Badimon, L.
    Rana-Miguez, P.
    Ruiz-Ortiz, M.
    Anguita, M.
    Lip, G. Y. H.
    Marin, F.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1295 - 1295
  • [34] Effectiveness and safety of dabigatran in Latin American patients with atrial fibrillation: Two years follow up results from GLORIA-AF registry
    Dubner, Sergio
    Saraiva, Jose Francisco Kerr
    Nunez Fragoso, Juan Carlos
    Baron-Esquivias, Gonzalo
    Teutsch, Christine
    Gurusamy, Venkatesh Kumar
    Marler, Sabrina
    Huisman, Menno, V
    Lip, Gregory Y. H.
    Zeballos, Cecilia
    IJC HEART & VASCULATURE, 2020, 31
  • [35] Gastrointestinal bleeding and cardiovascular events in patients with atrial fibrillation: results from the SAKURA AF registry and RAFFINE registry
    Abe, K.
    Wada, H. W.
    Miyauchi, K. M.
    Suwa, S. S.
    Miyazaki, S. M.
    Hayashi, H. H.
    Nishizaki, Y. N.
    Sumiyoshi, M. S.
    Nakazato, Y. N.
    Minamino, T. M.
    Okumura, Y. O.
    Daida, H. D.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [36] Major adverse cardiovascular events and mortality after catheter ablation in Japanese patients with atrial fibrillation: The Fushimi AF Registry
    Esato, Masahiro
    An, Yoshimori
    Ogawa, Hisashi
    Wada, Hiromichi
    Hasegawa, Koji
    Tsuji, Hikari
    Abe, Mitsuru
    Akao, Masaharu
    HEART AND VESSELS, 2021, 36 (08) : 1219 - 1227
  • [37] Major adverse cardiovascular events and mortality after catheter ablation in Japanese patients with atrial fibrillation: The Fushimi AF Registry
    Masahiro Esato
    Yoshimori An
    Hisashi Ogawa
    Hiromichi Wada
    Koji Hasegawa
    Hikari Tsuji
    Mitsuru Abe
    Masaharu Akao
    Heart and Vessels, 2021, 36 : 1219 - 1227
  • [38] Adherence to the Atrial Fibrillation Better Care (ABC) pathway and the risk of major outcomes in patients with atrial fibrillation: A post-hoc analysis from the prospective GLORIA-AF Registry
    Romiti, Giulio Francesco
    Proietti, Marco
    Bonini, Niccolo
    Ding, Wern Yew
    Boriani, Giuseppe
    Huisman, Menno, V
    Lip, Gregory Y. H.
    ECLINICALMEDICINE, 2023, 55
  • [39] Treatment persistence of patients with atrial fibrillation on VKA or NOAC: Data from GLORIA-AF Phase III 1-year interim analysis
    Lip, G. Y. H.
    Diener, H. -C.
    Dubner, S. J.
    Halperin, J. L.
    Rothman, K. J.
    Ma, C. -S.
    Lu, S.
    Paquette, M.
    Franca, L. Riou
    Zint, K.
    Teutsch, C.
    Huisman, M. V.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2987 - 2987
  • [40] INCREASED RATE OF PREVIOUS STROKE IN ASYMPTOMATIC/MINIMALLY SYMPTOMATIC VERSUS SYMPTOMATIC PATIENTS WITH NEWLY DETECTED ATRIAL FIBRILLATION WORLDWIDE: RESULTS FROM THE GLORIA-AF REGISTRY
    Christow, Steffen
    Seidl, Karlheinz
    Diener, Hans-Christoph
    Huisman, Menno
    Lip, Gregory
    Rauch-Kroenert, Ursula
    Schuster, Stefan
    Brachmann, Johannes
    Muegge, Andreas
    Schwimmbeck, Peter
    Teutsch, Christine
    Senges, Jochen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 450 - 450
12345